» Articles » PMID: 39061964

Recent Advances in Biomolecular Patho-Mechanistic Pathways Behind the Development and Progression of Diabetic Neuropathy

Overview
Journal Biomedicines
Date 2024 Jul 27
PMID 39061964
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic neuropathy (DN) is a neurodegenerative disorder that is primarily characterized by distal sensory loss, reduced mobility, and foot ulcers that may potentially lead to amputation. The multifaceted etiology of DN is linked to a range of inflammatory, vascular, metabolic, and other neurodegenerative factors. Chronic inflammation, endothelial dysfunction, and oxidative stress are the three basic biological changes that contribute to the development of DN. Although our understanding of the intricacies of DN has advanced significantly over the past decade, the distinctive mechanisms underlying the condition are still poorly understood, which may be the reason behind the lack of an effective treatment and cure for DN. The present study delivers a comprehensive understanding and highlights the potential role of the several pathways and molecular mechanisms underlying the etiopathogenesis of DN. Moreover, Schwann cells and satellite glial cells, as integral factors in the pathogenesis of DN, have been enlightened. This work will motivate allied research disciplines to gain a better understanding and analysis of the current state of the biomolecular mechanisms behind the pathogenesis of DN, which will be essential to effectively address every facet of DN, from prevention to treatment.

Citing Articles

Association of PTX3 Genetic Variants With Development of Diabetic Neuropathy.

Hsu Y, Fan Y, Su S, Chang L, Yang S In Vivo. 2025; 39(2):702-712.

PMID: 40010961 PMC: 11884479. DOI: 10.21873/invivo.13874.


Metabolomics in Pathogenic Pathways and Targeted Therapies for Diabetic Neuropathy: A Comprehensive Review.

Bala C, Rusu A, Ciobanu D, Roman G, Craciun A Metabolites. 2025; 15(2).

PMID: 39997711 PMC: 11857525. DOI: 10.3390/metabo15020086.


Diabetic peripheral neuropathy based on Schwann cell injury: mechanisms of cell death regulation and therapeutic perspectives.

Wu L, Wang X, Luo X, Zhang J, Zhao X, Chen Q Front Endocrinol (Lausanne). 2024; 15:1427679.

PMID: 39193373 PMC: 11348392. DOI: 10.3389/fendo.2024.1427679.

References
1.
Zakin E, Abrams R, Simpson D . Diabetic Neuropathy. Semin Neurol. 2019; 39(5):560-569. DOI: 10.1055/s-0039-1688978. View

2.
Cameron N, EATON S, Cotter M, Tesfaye S . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001; 44(11):1973-88. DOI: 10.1007/s001250100001. View

3.
Cammarota G, Cesaro P, Cazzato A, Cianci R, Fedeli P, Ojetti V . The water immersion technique is easy to learn for routine use during EGD for duodenal villous evaluation: a single-center 2-year experience. J Clin Gastroenterol. 2008; 43(3):244-8. DOI: 10.1097/MCG.0b013e318159c654. View

4.
Skaper S . Neurotrophic Factors: An Overview. Methods Mol Biol. 2017; 1727:1-17. DOI: 10.1007/978-1-4939-7571-6_1. View

5.
Andorfer B, Kieseier B, MATHEY E, Armati P, Pollard J, Oka N . Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol. 2001; 116(2):226-32. DOI: 10.1016/s0165-5728(01)00306-x. View